Caxton Associates (UK)’s CryoPort CYRX Stock Holding History

Caxton Associates (UK)’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-16,665	Closed	-$160K	–	833
2025 Q4	$160K	Buy	+16,665	New	+$157K	﹤0.01%	730

Other funds holding CYRX

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mirova Paris, France $2.71B AUM 27.78% 1-Year Est. Return

Caxton Associates (UK)'s CYRX Position: Q1 2026 in Review

Caxton Associates (UK) sold out of CryoPort (CYRX) in Q1 2026, closing a stake of 16,665 shares — an estimated $160K sold.

Caxton Associates (UK) first reported a position in CYRX in Q4 2025 and held it in 1 quarter. The position peaked at $160K in Q4 2025. 165 funds tracked by Wall St. Rank hold CYRX as of Q1 2026.

Caxton Associates (UK) reported no remaining CryoPort position as of Q1 2026 after selling out during the quarter.
Caxton Associates (UK) sold 16,665 CryoPort shares in Q1 2026, an estimated $160K.
Caxton Associates (UK) first reported a position in CryoPort in Q4 2025 and held it in 1 quarter.
Caxton Associates (UK)'s CryoPort position peaked at $160K in Q4 2025.
165 funds tracked by Wall St. Rank held CryoPort as of Q1 2026.

Based on Caxton Associates (UK)'s 13F filing for Q1 2026, filed 14 May 2026.